NEW YORK (GenomeWeb) – Twist Bioscience announced today that it has acquired Israeli synthetic biology software company Genome Compiler.

Under the terms of the agreement, the Genome Compiler research and development center in Israel will remain open as Twist's first international site. Financial terms of the deal were not disclosed.

Twist said it plans to use Genome Compiler's technology and expertise to develop a digital products portfolio, including an e-commerce solution with gene design capabilities, which is expected to be available in the second half of 2016.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.